Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-11-09 00:00:00 ET · period of report 2022-11-07 · accession 0000899243-22-035443 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-09 | 2022-11-07 | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | S - Sale+OE | $303.04 | -1,303 | 36.2K | -3% | -$394.9K |
| D | 2022-11-09 | 2022-11-07 | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | M - OptEx | $187.53 | +1,303 | 37.4K | +4% | +$244.4K |
| D | 2022-11-09 | 2022-11-07 | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | M - OptEx | $0.00 | -1,303 | 1,304 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-07 | S | D | 189 | $301.99 | 36,841 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $301.99 (range $301.84 to $302.20). (F2) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2022-11-07 | S | D | 83 | $306.57 | 36,077 | D | — | — | (F9) Open market sales reported on this line occurred at a weighted average price of $306.57 (range $306.45 to $307.22). (F2) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2022-11-07 | M | A | 1,303 | $187.53 | 37,380 | D | — | — | |
| 4 | Common | Common Stock | 2022-11-07 | S | D | 140 | $299.72 | 37,240 | D | — | — | (F3) Open market sales reported on this line occurred at a weighted average price of $299.72 (range $299.46 to $299.97). (F2) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2022-11-07 | S | D | 210 | $300.96 | 37,030 | D | — | — | (F4) Open market sales reported on this line occurred at a weighted average price of $300.96 (range $300.54 to $301.18). (F2) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common Stock | 2022-11-07 | S | D | 261 | $303.21 | 36,580 | D | — | — | (F6) Open market sales reported on this line occurred at a weighted average price of $303.21 (range $302.89 to $303.45). (F2) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2022-11-07 | S | D | 280 | $304.58 | 36,300 | D | — | — | (F7) Open market sales reported on this line occurred at a weighted average price of $304.58 (range $304.14 to $304.91). (F2) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 8 | Common | Common Stock | 2022-11-07 | S | D | 140 | $305.39 | 36,160 | D | — | — | (F8) Open market sales reported on this line occurred at a weighted average price of $305.39 (range $305.38 to $305.39). (F2) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 9 | Derivative | Stock Option (Right to Buy) | 2022-11-07 | M | D | 1,303 | $0.00 | 1,304 | D | $187.53 · — to 2029-02-05 | 1,303 Common Stock | (F10) The option vests in 16 quarterly installments from 2/6/2019. |